Prognostic Value of Log Odds of Positive Lymph Nodes after Radical Surgery Followed by Adjuvant Treatment in High-Risk Cervical Cancer
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study is to compare the prognostic efficacy of the number and location of positive lymph nodes (LN), LN ratio (LNR), and log odds of positive LNs (LODDs) in highrisk cervical cancer treated with radical surgery and adjuvant treatment. Materials and Methods Fifty high-risk patients who underwent radical hysterectomy and pelvic node dissection followed by adjuvant treatment were analyzed retrospectively. The patients had International Federation of Gynecology and Obstetrics (FIGO) stage IA2-IIB. Upper LN is defined as common iliac or higher LN, and LNR is the ratio of positive LNs to harvested LNs. LODDs is log odds between positive LNs and negative LNs. Radiotherapy was delivered to the whole pelvis with median 50.4 Gy/28 Fx± to the para-aortic regions. Platinum-based chemotherapy was used in most patients (93%). The median follow-up duration was 80 months. Results The 5-year disease-free survival (DFS) rate was 76.1%, and the overall survival (OS) rate was 86.4%. Treatment failure occurred in 11 patients, and distant failure (DF) was the dominant pattern (90.9%). In univariate analysis, significantly lower DFS was observed in patients with perineural invasion, ! 2 LN metastases, LNR ! 10%, upper LN metastasis, and ! –1.05 LODDs. In multivariate analysis, ! –1.05 LODDs was the only significant factor for DFS (p=0.011). Of patients with LODDs ! –1.05, 40.9% experienced DF. LODDs was the only significant prognostic factor for OS as well (p=0.006). Conclusion LODDs ! –1.05 was the only significant prognostic factor for both DFS and OS. In patients with LODDs ! –1.05, intensified chemotherapy might be required, considering the high rate of DF.
Abstract
Purpose The purpose of this study is to compare the prognostic efficacy of the number and location of positive lymph nodes (LN), LN ratio (LNR), and log odds of positive LNs (LODDs) in highrisk cervical cancer treated with radical surgery and adjuvant treatment. Materials and Methods Fifty high-risk patients who underwent radical hysterectomy and pelvic node dissection followed by adjuvant treatment were analyzed retrospectively. The patients had International Federation of Gynecology and Obstetrics (FIGO) stage IA2-IIB. Upper LN is defined as common iliac or higher LN, and LNR is the ratio of positive LNs to harvested LNs. LODDs is log odds between positive LNs and negative LNs. Radiotherapy was delivered to the whole pelvis with median 50.4 Gy/28 Fx± to the para-aortic regions. Platinum-based chemotherapy was used in most patients (93%). The median follow-up duration was 80 months. Results The 5-year disease-free survival (DFS) rate was 76.1%, and the overall survival (OS) rate was 86.4%. Treatment failure occurred in 11 patients, and distant failure (DF) was the dominant pattern (90.9%). In univariate analysis, significantly lower DFS was observed in patients with perineural invasion, ! 2 LN metastases, LNR ! 10%, upper LN metastasis, and ! –1.05 LODDs. In multivariate analysis, ! –1.05 LODDs was the only significant factor for DFS (p=0.011). Of patients with LODDs ! –1.05, 40.9% experienced DF. LODDs was the only significant prognostic factor for OS as well (p=0.006). Conclusion LODDs ! –1.05 was the only significant prognostic factor for both DFS and OS. In patients with LODDs ! –1.05, intensified chemotherapy might be required, considering the high rate of DF.
참고문헌 (21)
- Rotman M, "A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features : follow-up of a gynecologic oncology group study", Int J Radiat Oncol Biol Phys, 65, pp.169~176 (2006)
- Song S, "20year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors : impact of treatment period and concurrent chemotherapy", Gynecol Oncol, 124, pp.63~67 (2012)
- 김우영, "Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification", Journal of Gynecologic Oncology, 20(1), pp.17~21 (2009), 대한부인종양학회
- Piura B, "Recurrent cervical carcinoma after radical hysterectomy and pelvic lymph node dissection : a study of 32 cases", Eur J Gynaecol Oncol, 29, pp.31~36 (2008)
- Tsai CS, "The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy", Gynecol Oncol, 75, pp.328~333 (1999)
- Lin HH, "Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation", Obstet Gynecol, 88, pp.274~279 (1996)
- 김희승, "Phase II Study of Consolidation Chemotherapy after Adjuvant or Primary Concurrent Chemoradiation Using Paclitaxel and Carboplatin to Treat High-Risk Early-Stage or Locally Advanced Cervical Cancer", Cancer Research and Treatment, 44(2), pp.97~103 (2012), 대한암학회[DOI]
- Lee JW, "Preliminary results of consolidation chemotherapy following concurrent chemoradiation after radical surgery in high-risk early-stage carcinoma of the uterine cervix", Clin Oncol(R Coll Radiol), 17, pp.412~417 (2005)
- Compton CC, "AJCC cancer staging atlas : a companion to the seventh editions of the AJCC cancer staging manual and handbook" (2012), Springer
- Monk BJ, "Rethinking the use of radiation and chemotherapy after radical hysterectomy : a clinical-pathologic analysis of a Gynecologic Oncology Group", Southwest Oncology Group, Gynecol Oncol, pp.2005, 96[DOI]
- Kidd EA, "Lymph node staging by positron emission tomography in cervical cancer : relationship to prognosis", J Clin Oncol, 28, pp.2108~2113 (2010)
- Demirci S, "Evaluation of treatment results and prognostic factors in early-stage cervical carcinoma patients treated with postoperative radiotherapy or radiochemotherapy", Eur J Gynaecol Oncol, 33, pp.62~67 (2012)
- Pecorelli S, "Revised FIGO staging for carcinoma of the cervix", Int J Gynaecol Obstet, 105, pp.107~108 (2009)
- Takeda N, "Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy", Acta Obstet Gynecol Scand, 81, pp.1144~1151 (2002)
- Polterauer S, "The impact of lymph node density on survival of cervical cancer patients", Br J Cancer, 103, pp.613~616 (2010)
- Wang J, "The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer", J Gastrointest Surg, 12, pp.1790~1796 (2008)
- Sun Z, "Log odds of positive lymph nodes : a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection", Cancer, 116, pp.2571~2580 (2010)
- Peters WA 3rd, "Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix", J Clin Oncol, 18, pp.1606~1613 (2000)
- Soisson AP, "Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer", Gynecol Oncol, 37, pp.390~395 (1990)
- Kim MK, "Postoperative nomogram predicting risk of recurrence after radical hysterectomy for early-stage cervical cancer", Int J Gynecol Cancer, 20, pp.1581~1586 (2010)
- Lee HJ, "Individualized prediction of overall survival after postoperative radiation therapy in patients with early-stage cervical cancer : a Korean Radiation Oncology Group study(KROG 13-03)", Int J Radiat Oncol Biol Phys, 87, pp.659~664 (2013)